Longevity Blood Markers: The Tests That Actually Matter | YEARS

Why Standard Blood Tests Are Often Not Enough for Longevity

You go to preventive check-ups regularly and have your blood tested. That is an important first step. But what if this check-up only captures part of your long-term health risks? What if relevant signals for your future health remain invisible in a standard profile?

The standard check-up is designed to detect common diseases and risk factors early, not to create a full strategy for extending your healthspan. It is an important safety net, but not a complete system for long-term prevention. For longevity-oriented health planning, you need a broader and more differentiated data picture.

This article explains why a standard blood test is often not enough and which specific biomarkers may be relevant today to assess your health more proactively over decades.

Why Standard Blood Tests Are Not Enough for Longevity

From the age of 35, people with statutory health insurance in Germany are entitled to the “Check-up 35.” This program includes a medical consultation, physical examination, blood pressure measurement, laboratory values such as lipid profile and fasting plasma glucose, urine analysis, and medical counseling. This is medically useful, but it is deliberately focused on basic risks and common diseases.

The issue lies in the objective: these markers help detect important existing risks or diseases such as diabetes, lipid disorders, kidney disease, or high blood pressure. Many earlier risk patterns that can develop years before the first symptom remain only partly visible. Cardiovascular disease, metabolic disorders, and chronic low-grade inflammation often develop over long periods of time. Markers such as insulin resistance, atherogenic particle number, or genetic lipid risks are not usually part of the standard check-up.

Relevant blood values for longevity-oriented risk assessment are often missing:

ApoB, a highly informative marker for the number of atherogenic lipoprotein particles.

Lp(a), a largely genetic risk factor for atherosclerotic cardiovascular disease and aortic valve stenosis.

HOMA Index, which can provide signs of insulin resistance before fasting glucose becomes abnormal.

hs-CRP, a marker of low-grade systemic inflammation.

Relevant micronutrients such as vitamin D3 and ferritin.

A longevity-oriented blood panel closes this gap. The goal is not to measure as many values as possible. What matters is interpreting the right markers correctly and translating them into meaningful, prioritized actions.

Cardiovascular Blood Markers: ApoB, Lp(a), and hs-CRP

Cardiovascular disease usually does not appear out of nowhere. It is often the result of processes that develop over many years. Three biomarkers can provide a clearer picture than total cholesterol alone.

ApoB: The Particle Counter for Cardiovascular Risk

Your physician often measures LDL cholesterol, commonly called “bad” cholesterol. Imagine LDL particles as cargo ships transporting cholesterol through your arteries. The LDL value measures the cargo. Apolipoprotein B (ApoB), on the other hand, counts the number of ships. This particle number is especially relevant for plaque development in the artery wall.

Every atherogenic particle in the blood, whether LDL, VLDL, or IDL, carries one ApoB molecule on its surface. Studies show that ApoB can complement and, in certain situations, improve cardiovascular risk assessment compared with LDL cholesterol, especially when LDL-C and particle number differ. Two people may have similar LDL values but different ApoB values, which can point to different risk profiles.

Lp(a): The Genetic Risk Factor Many People Do Not Know

Lipoprotein(a), or Lp(a), is a blood lipid value that is largely genetically determined. Elevated Lp(a) is associated with a higher risk of heart attack, stroke, and aortic valve stenosis, independent of many traditional risk factors.

Lp(a) is usually not measured in a standard blood test. This matters because people with low LDL cholesterol and a healthy lifestyle can still carry additional risk due to high Lp(a). Since the value is strongly shaped by genetics, a one-time measurement in adulthood is often enough, unless special clinical circumstances apply.

hs-CRP: The Marker for Low-Grade Inflammation

Chronic low-grade inflammation can influence aging processes and chronic disease. High-sensitivity C-reactive protein (hs-CRP) is an established blood marker for estimating systemic inflammatory activity. The JUPITER trial showed that people with elevated hs-CRP and non-elevated LDL cholesterol had fewer cardiovascular events under rosuvastatin. These findings are important, but they should not be understood to mean that hs-CRP alone determines treatment decisions.

An hs-CRP value below 1 mg/L is often considered favorable. Values above that can indicate increased risk or current inflammatory activity, but they are non-specific. Infections, intense training, poor sleep, body fat, metabolic dysfunction, and other factors can influence the value. That is why hs-CRP must always be assessed within the full clinical picture.

These three markers, ApoB, Lp(a), and hs-CRP, form an important foundation of modern cardiovascular prevention. At YEARS, they are included as standard in the YEARS Core® Program. An elevated value is not a diagnosis. It is a signal that requires medical interpretation and a clear strategy.

Metabolic Markers: HOMA Index, Fasting Insulin, and OGTT

Your metabolic health is a central factor for long-term health. Standard fasting glucose is only one part of the picture. It can still look normal even when the body already needs more insulin to keep glucose stable.

HOMA Index: An Early Signal for Insulin Resistance

The Homeostasis Model Assessment Index (HOMA Index) is calculated from fasting insulin and fasting glucose and provides information about how sensitive your body is to insulin. An elevated HOMA Index can indicate insulin resistance, a central driver of metabolic syndrome, which is associated with fatty liver, high blood pressure, increased cardiovascular risk, and impaired glucose regulation.

A HOMA Index above 2.5 is often discussed as a warning range, but optimal cut-offs can vary depending on population, laboratory, age, sex, and metabolic state. The value should therefore not be interpreted on its own. It makes sense to assess it together with HbA1c, triglycerides, HDL, liver markers, body composition, blood pressure, and, when appropriate, an OGTT.

OGTT: The Stress Test for Your Blood Sugar

Normal fasting glucose can be misleading. The real stress test for your metabolism is your response to a defined glucose load. The oral glucose tolerance test (OGTT) simulates exactly that: you drink a defined glucose solution, and your blood glucose is measured over two hours.

The test can reveal impaired glucose tolerance that would have remained unnoticed in fasting measurements. If insulin values are measured as well, excessive insulin secretion can also become visible. This is especially relevant when someone seems to have normal routine lab values but may already be developing early metabolic abnormalities.

The HOMA Index and OGTT are part of the basic diagnostics and are included in the YEARS Core® Program.

Inflammation & Cellular Health: IL-6, Homocysteine, and Oxidized LDL

Beyond hs-CRP, there are additional markers that can provide a more differentiated picture of inflammatory activity, vascular health, and cellular stress. These values are more specialized and are not part of every basic longevity screening.

Inflammaging: Aging as an Inflammatory Process

“Inflammaging” describes a state of chronic, low-grade inflammation that can increase with age and is linked to many age-associated diseases, including atherosclerosis, metabolic disease, neurodegenerative processes, and certain cancers.

Specific Inflammatory Markers

Interleukin-6 (IL-6): This cytokine is involved in inflammatory reactions. Chronically elevated IL-6 levels are associated in studies with cardiovascular disease, sarcopenia, and cognitive decline in older age. The value is dynamic and can be influenced by infections, training, body fat, stress, and other factors.

Homocysteine: This amino acid is associated with cardiovascular disease and neurodegenerative processes. Elevated values can, among other things, point to a deficiency in B vitamins such as B6, B12, or folate. Targeted supplementation can often lower homocysteine values, but lowering a lab value does not automatically mean that clinical outcomes improve to the same degree. A value below 10 µmol/L is often targeted, depending on laboratory, clinical picture, and risk profile.

Oxidized LDL (oxLDL): LDL particles can be altered by oxidative processes. Oxidized LDL is involved in inflammatory processes in the vascular wall and in the development of atherosclerotic plaques. The marker can provide additional information, but it is not established as a standard marker across all guidelines.

These advanced markers are part of the extended laboratory panel in the YEARS Evolve® Program. Since they are dynamic values, medical interpretation within the full health picture is especially important.

Hormones & Micronutrients: What Can Become Relevant From Age 35

Long before organs become diseased, regulatory systems can shift out of balance. Hormones and micronutrients play an important role here, but they should never be assessed in isolation.

Vitamin D3: The Sun Hormone With Systemic Effects

Vitamin D acts like a hormone in the body and plays an important role in bone metabolism, muscle function, and the immune system. Low vitamin D levels are common in Germany. According to the Robert Koch Institute, many adults do not reach an adequate 25(OH)D level.

Low vitamin D levels are associated with various health risks, including bone problems, susceptibility to infections, and certain chronic diseases. However, many of these links come from observational data and do not automatically prove that vitamin D supplementation reduces all associated risks. Measuring vitamin D is especially useful to detect and correct deficiency in a targeted way.

Ferritin: The Double-Edged Marker of Iron Storage

Ferritin shows how much iron your body has stored. Iron deficiency can contribute to fatigue, reduced performance, and cognitive difficulties. Excess iron, on the other hand, can support pro-oxidative processes and should also be clarified.

Balance matters. Optimal values depend on sex, menstrual status, nutrition, inflammatory status, physical activity, and symptoms. Ferritin should therefore be assessed together with hemoglobin, MCV/MCH, transferrin saturation, CRP, and the clinical picture. Iron supplementation should only be used when there is confirmed need and medical supervision.

The Hormonal Axis: Testosterone, DHEA-S, and Cortisol

With increasing age, hormonal axes can change. This varies strongly from person to person and should not be framed as a general decline starting at 35.

Testosterone influences muscle mass, bone density, energy, libido, and well-being. Interpretation strongly depends on age, sex, symptoms, SHBG, free testosterone, time of measurement, and accompanying factors. A single value in the lower reference range is not a diagnosis.

DHEA-S is a precursor of several steroid hormones. Levels decline in many people with age. Whether a low value is clinically relevant depends on the full picture and should not be assessed in isolation.

Cortisol, the stress hormone, follows a daily rhythm: usually higher in the morning and lower later in the day. Cortisol values can provide information about stress-axis activity. They become meaningful only when timing, sleep, medication, acute stressors, symptoms, and clinical question are considered. A single cortisol value is not a simple stress score.

The basic micronutrients vitamin D3 and ferritin are included in the YEARS Core® Program. The differentiated hormone analysis with testosterone, DHEA-S, and cortisol requires particularly careful medical interpretation and is therefore part of the YEARS Evolve® Program.

Measuring Biological Age: Epigenetic Clocks as an Additional Layer

Why does one person age differently at 50 than another? The answer lies not only in the calendar, but also in biological processes. Your chronological age is fixed. Your biological age describes, in simplified terms, the state of your cells, tissues, and organ systems.

Epigenetic Clocks: A View of Molecular Aging Markers

Epigenetics describes changes to DNA that do not alter the gene sequence itself, but influence gene activity. DNA methylation is one of these mechanisms. With age, certain methylation patterns change in predictable ways. Epigenetic clocks such as Horvath, GrimAge, or DunedinPACE analyze many of these methylation sites and estimate biological aging markers or aging pace.

This is scientifically interesting, but not a classic diagnostic test. Studies show that certain epigenetic clocks are associated with mortality, disease risks, and functional changes. For individual medical decisions, standardization, clinical validation, and interpretation remain limited.

What Do You Do With the Result?

Epigenetic clocks are currently mainly research and tracking markers with growing practical relevance. Their value lies in providing additional information on biological aging processes and observing changes over time.

They should not be understood as a diagnosis, life expectancy forecast, or standalone basis for medical decisions. Claims such as “reversing biological age” should also be used carefully because measurements can fluctuate, and not every change automatically means a clinically relevant effect.

Measurement of several epigenetic clocks is part of the YEARS Evolve® Program.

What YEARS Measures: Core®, Evolve®, and Ultimate® Compared

To get a complete picture, blood values alone are not enough. YEARS integrates relevant laboratory biomarkers with functional and imaging diagnostics in a single day.

Two points for orientation: YEARS does not perform routine screening for infectious diseases such as hepatitis, because this is a different medical question and should be handled based on indication. For lung function, YEARS uses body plethysmography, a procedure that can provide additional information on lung volumes and airway resistance.

Compare the programs in detail:

YEARS Core® Program

YEARS Evolve® Program

YEARS Ultimate® Program

Conclusion: When Should You Start Measuring Longevity Blood Markers?

A useful orientation is this: from around age 35, it can be helpful to look at extended blood values and functional health markers. If you have a family history, such as heart attacks, diabetes, or cancer before age 60 in close relatives, starting earlier may make sense.

The Check-up 35 is an important safety net. People who want to manage their health proactively often need more data and a more differentiated analysis. The five most important markers many people over 35 should know are:

ApoB

Lp(a)

HOMA Index

hs-CRP

Vitamin D3

All of these markers are included in the YEARS Core® Program, together with diagnostics that go beyond a pure blood test.

Longevity medicine is not a one-time event. The greatest value lies in regular monitoring. Single measurements are snapshots. Only the trend over years shows patterns and makes it visible whether interventions are working. People who start collecting data now will have a better basis for real decisions in the years ahead.

Would you like to create a foundation for your longevity strategy?

Learn more about the YEARS Core® Program.

Do you have questions about which program is right for you?

Schedule a non-binding consultation.

Frequently Asked Questions (FAQ)

Which Blood Values Are Most Important for Longevity?

For a starting point, five markers are especially relevant: ApoB for the number of atherogenic particles, Lp(a) as a genetically shaped risk factor, HOMA Index as a sign of insulin resistance, hs-CRP as an inflammation marker, and vitamin D3 as a marker of micronutrient status, bone metabolism, and immune function. These values provide information on central risk areas and are included in the YEARS Core® Program.

What Does Check-up 35 Measure, and What Does It Miss?

Check-up 35 includes medical history, physical examination, blood pressure measurement, laboratory values such as lipid profile and fasting plasma glucose, urine analysis, and counseling. Modern add-on markers for extended longevity-oriented risk assessment are usually missing, including HOMA Index, ApoB, Lp(a), hs-CRP, or differentiated micronutrient and hormone analyses. Differentiated hormone analysis with testosterone, DHEA-S, and cortisol is not included in Check-up 35 or in YEARS Core®, but is part of the YEARS Evolve® Program.

From What Age Should I Measure Extended Longevity Blood Values?

From around age 35, a broad baseline can be useful. If you have a family history such as early heart attacks, diabetes, or cancer, starting earlier may be advisable. Genetic factors such as Lp(a) can generally be measured once in adulthood.

What Is the Difference Between Biological and Chronological Age?

Your chronological age is the time since your birth. Your biological age describes, in simplified terms, the state of your cells, tissues, and organ systems. It is influenced by genetics, lifestyle, nutrition, movement, sleep, stress, environmental factors, and disease. Epigenetic clocks can estimate biological aging markers and make them observable over time. They are not a diagnosis or a life expectancy forecast.

Medical disclaimer: This article is for general information and does not replace individual medical advice or diagnosis. Biomarker results must always be interpreted by a physician within the full clinical picture.

Sources

Aguilar-Salinas, C. A., et al. (2020). The HOMA of Insulin Resistance in the Assessment of Metabolic Status. Adipocyte, 9(1), 579-585. DOI: 10.1080/21623945.2020.1834246.

German Federal Ministry of Health. Preventive health examination / Check-up. Accessed June 2026.

Ference, B. A., et al. (2018). Apolipoprotein B, low-density lipoprotein cholesterol, non-HDL cholesterol, and cardiovascular disease risk. The Lancet, 392(10153), 1085-1094. DOI: 10.1016/S0140-6736(18)31644-X.

Kronenberg, F., Mora, S., Stroes, E. S., Ference, B. A., Arsenault, B. J., Berglund, L., ... & Nordestgaard, B. G. (2022). Lipoprotein(a), atherosclerotic cardiovascular disease, and aortic stenosis: European Atherosclerosis Society consensus statement. European Heart Journal, 43(39), 3925-3946. DOI: 10.1093/eurheartj/ehac361.

Rabenberg, M., et al. (2015). Vitamin D status among adults in Germany: results from DEGS1. BMC Public Health, 15, 641.

Ridker, P. M., et al. (2008). Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. New England Journal of Medicine, 359(21), 2195-2207. DOI: 10.1056/NEJMoa0807646.

Tsimikas, S. (2018). Lipoprotein(a): An Important Causal Risk Factor Comes of Age. Journal of the American College of Cardiology, 71(1), 68-82. DOI: 10.1016/j.jacc.2017.11.003.

Vaiserman, A., et al. (2022). The role of immunosenescence in age-related diseases. Ageing Research Reviews, 75, 101569. DOI: 10.1016/j.arr.2022.101569.

Apsley, A. T., et al. (2025). From Population Science to the Clinic? Limits of Epigenetic Clocks for Individual-Level Decision Making. Review literature on clinical utility and limitations of epigenetic clocks.